Event Calendar
Meet us at one the following industry events
UPCOMING EVENTS
December 9, 2020 – The Challenge of Variant Interpretation: Leveraging Genetic and Clinical Evidence to Improve the Diagnosis of Rare Diseases
In this webinar, speakers from Limbus Medical Technologies, MGZ, and Genomenon will tell you from their perspectives what is necessary to successfully accept challenges in clinical routine and what tools are available and needed to accelerate and improve the diagnostic process. Register now and learn how to tackle the bottleneck of variant interpretation in clinical routine and get an overview about the best tools available to support you to provide accurate clinical recommendations. Join our experts live to get hands-on insights and take the opportunity to get answers to your questions!
Learn more and register
PREVIOUS EVENTS
November 23-26, 2020 – Biotechgate Digital Partnering
Biotechgate Digital Partnering is focusing on companies developing drugs, diagnostics and medical devices. If we were unable to connect at this event, email us to schedule a meeting with our team.
Email us here
November 18-19, 2020 – Orphan Drug & Rare Disease Global Congress
The two-day Congress provided an interactive, cutting edge and comprehensive discussion and networking format led by key experts with intimate knowledge in the industry. Attendees collaborated on practical strategies and best practices on challenges, innovations, technologies and concepts surrounding orphan drugs and rare diseases. Co-founder and Chief Science Officer Dr. Mark Kiel presented ‘Big Data for Rare Disease: Comprehensive Genomic Landscapes to Accelerate Drug Development’. Email to learn more about our genomic solutions for Pharma.
Email us here
November 16-20, 2020 – AMP 2020 Virtual Meeting & Expo
The 2020 AMP meeting explored how cutting-edge technology and developments in molecular testing and diagnostics continue to have a major impact on patient care, and ways in which our community remains at the forefront of precision medicine.
Learn more about this event
November 18, 2020 – Rapid WGS: How Rady Children’s Institute Is Increasing Diagnostic Yield and Improving Outcomes
In this webinar, Dr. Stephen Kingsmore, President and CEO of Rady Children’s Institute for Genomic Medicine, gave an executive overview of the two-time world-record-setting Rady rWGS method, followed by a deeper examination of the institute’s analysis and interpretation pipeline by Dr. Katarzyna (Kasia) Ellsworth. The presentation included a demonstration of the Rady literature curation process that is powered by the Mastermind Genomic Search Engine.
Watch the Recording
November 10-11, 2020 – Biomarkers for Rare Non-Oncological Diseases Summit
The 2nd Annual Biomarkers for Rare Non-Oncological Diseases Summit united biopharma, diagnostic and healthcare teams to advance the application of precision medicine in rare diseases beyond oncology. If you were unable to visit our virtual booth, email us to schedule a meeting with our team to learn more about our genomic solutions.
Email us here
November 3, 2020 – Webinar: Artificial Intelligence (AI) 101
The National Society of Genetic Counselors hosted a free, CEU-eligible webinar titled Artificial Intelligence (AI) 101 with guest speaker Dr. Mark Kiel, co-founder and Chief Science Officer at Genomenon. Attendees learned about the fundamentals of Artificial Intelligence and its implication in medical genomics—now and in the future. Contact us to learn more.
Email us here
October 27-30, 2020 – ASHG 2020 Virtual Meeting
The ASHG 2020 Virtual Meeting featured action-packed plenary & platform talks and invited sessions showcasing speakers who inspired and energized attendees with their cutting-edge research and ideas, including highlighting some of the most exciting work in genetics and genomics. If we missed you at ASHG 2020, email us to schedule a meeting with our leadership team.
Email us here
October 15, 2020 – Mastermind Masterclass: CNV Search
In this webinar, co-founders, CSO Dr. Mark Kiel and CTO Steve Schwartz take a use-case approach to highlighting the new CNV capability and showcase the benefits that Mastermind can provide to cytogeneticists and variant scientists when searching for CNVs, large and small.
Watch the Recording
October 6-8, 2020 – Bio-IT World Conference & Expo
Bio-IT World unites an ecosystem of over 3,000 leading life sciences, pharmaceutical, clinical, healthcare, informatics and technology experts in the field of biomedical research, drug discovery & development, and healthcare from around the world. Genomenon is a 2019 Bio-IT World Best in Show Award Winner.
If we missed you at this event, email our team to learn more about our genomic solutions for Pharma.
Email us here
September 29-October 1, 2020 – 1st Digital Clinical Biomarkers & World CDx
Uniting biomarker, translational, clinical, diagnostic and commercial thought leaders, the Digital Clinical Biomarkers & World CDx meeting addressed key questions raised following the rapid COVID-19 response and delivered exciting case studies from pioneering teams in personalized therapeutics. If we missed you at this event, email our team to learn more about our genomic solutions for Pharma.
Email us here
September 24-25, 2020 – PharmaTec Series
Genomenon presented at this event that had over 500 leaders, experts and scientists discussing and examining the latest technologies, developments and future thinking in Pharma-related IT, AI and SmartLabs. Co-founder & CSO Dr. Mark Kiel is presented, “Big Data for Rare Disease: Comprehensive Genomic Landscapes to Accelerate Drug Development”.
Watch Dr. Kiel’s presentation here
September 17, 2020 – New Enterprise Foundation (NEF) Showcase
Genomenon CEO Mike Klein joined a panel of experts to discuss how entrepreneurs are responding to the unusual conditions of the COVID-19 pandemic and will share their perspectives on operating in a virtual world and explained the B2B sales and marketing strategies they are deploying to meet the unique challenges of acquiring new customers in the midst of lockdown orders, an economic crisis and a public health emergency.
September 1, 2020 – MATTER Startup Showcase
Genomenon co-founder and CSO Mark Kiel, MD, PhD, presented real-world examples to demonstrate how Mastermind Genomic Landscapes empower pharmaceutical researchers and translational teams to understand rare diseases at the molecular level.
Learn more about MATTER
August 27, 2020 – Mastermind Masterclass: Sensitivity & Specificity in Genomic Search
Genomenon co-founders Dr. Mark Kiel and Steve Schwartz discuss how Mastermind optimizes specificity and then sensitivity when searching for insight into patient variants and resolving VUSs for optimal diagnostic yield.
View the recording here
August 25-27, 2020 – 12th Annual Next Generation Dx Global Virtual Summit
Since 2009, the diagnostics community has united at Next Generation Dx Summit to discuss trend-setting developments, milestones, challenges and opportunities in the industry. As the market demands faster and more precise diagnostics, and regulatory and reimbursement conditions continue to evolve, diagnostic professionals need a comprehensive event that can help them build partnerships, gain industry knowledge, and network with and learn from their peers. Connect with our leadership team to learn more about Genomenon.
Email us here
August 24-27, 2020 – Global Orphan Drug Conference
Genomenon enjoyed attending this virtual event and connecting with those addressing the most pressing challenges and opportunities to bring rare disease therapies to patients faster. To connect with our leadership team and learn about our work with our rare disease partners, please contact us at the link below.
Email us here
August 6-8, 2020 – Neuroimmunology Drug Development Summit
More and more pharma and biotech companies are investing in research focused on neuroimmunology and neuroinflammation’s relation to neurodegenerative diseases in the challenge to develop clinically effective therapeutics. Members of the Genomenon leadership team attended this virtual event. To connect with our team about partnering, please email us below.
Email us here
July 22, 2020 – Mastermind Masterclass: Genomic Associations
In this Masterclass, co-founders, CSO Dr. Mark Kiel and CTO Steve Schwartz describe how to harness the power of comprehensive evidence-based data for use in clinical workflows to answer specific questions about genes and variants, as well as in drug discovery to answer more open-ended questions and uncover associations that were not previously known to the searcher.
View the recording here
July 8, 2020 – Webinar with Congenica: How to Gain Immediate Insight into Clinically Relevant Evidence
In this webinar, Helen Savage, DipRCPath, Deputy Head of Clinical Services at Congenica and Genomenon CSO Mark Kiel, MD, PhD, look at a key part of the clinical interpretation workflow and reveal how a combination of new tools is helping to break through the interpretation bottleneck, enabling you to instantly identify and analyze genetic evidence found across the complete corpus of scientific articles, faster and with greater confidence than ever before.
View the recording here
June 30, 2020 – Big Data for Rare Disease Pharma: Using Genomic Landscapes to Accelerate Drug Development
In this webinar, Genomenon co-founder and CSO Mark Kiel, MD, PhD, uses real-world examples to demonstrate how Mastermind Genomic Landscapes have empowered pharmaceutical researchers and translational teams to understand rare diseases at the molecular level.
View the recording here
June 25, 2020 – Mastermind Masterclass: ACMG/AMP Classification
Co-founders, CSO Dr. Mark Kiel and CTO Steve Schwartz led a live discussion and demonstration of the ACMG/AMP filtering process in the Mastermind Genomic Search Engine.
View the recording here
June 8-12, 2020 – BIO Digital
The BIO International Convention transitioned to a new, virtual event format, BIO Digital. We were excited to have been a part of this virtual gathering of global biotech industry experts. Genomenon CEO, Mike Klein and CSO Dr. Mark Kiel partnered at this event thru the One-On-One Platform. If we were unable to connect at BIO, please email us below to connect with a member of our leadership team.
Email us here
June 11-12, 2020 – RARE Drug Development Symposium
Genomenon attended the RARE Drug Development Symposium, a two-day interactive virtual event in partnership with The Penn Medicine Orphan Disease Center that focused on educating both beginners and advanced participants on the drug development process. If we were unable to connect at RDDS, please email us below to connect with a member of our leadership team.
Email us here
June 6-8, 2020 – European Society of Human Genetics (ESHG)
Genomenon exhibited – virtual
The Genomenon team was looking forward to our first International event and after the change to a virtual format, we enjoyed connecting with attendees & speakers. If we were unable to connect at ESHG, please email us below to connect with a member of our leadership team.
Email us here
May 21, 2020 – Pharma Webinar: Gaining Insight into Known and Novel Therapies to Drive Drug Discovery
In this webinar, Dr. Mark Kiel demonstrated how therapeutic associations between diseases, genes, variants, and phenotypes are a powerful tool in drug development.
View the recording and Q&A here
May 20, 2020 – LabRoots 4th Annual Laboratory Automation & Informatics Virtual Event
Genomenon co-founder & CSO Dr. Mark Kiel presented at the LabRoots Laboratory Automation & Informatics Virtual Event: ‘Comprehensive Genomic Association Data for Genetic Variant Interpretation: A Computational Approach’.
Learn more and watch on-demand
May 14, 2020 – Mastermind Masterclass: Therapies
Learn the latest from the architects of Mastermind with the Masterclass webinar series! The Mastermind Genomic Search Engine now includes the ability to search the genomic literature by therapy. Co-founders Dr. Mark Kiel and Steve Schwartz led a concise guided tour of the new Therapies search feature and live Q&A.
View the recording and Q&A here
April 27-28, 2020 – AACR Virtual Annual Meeting
Genomenon joined The Virtual AACR Annual Meeting program which covered the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlighted the work of the best minds in research and medicine from institutions all over the world. To connect with our leadership team, please email us below.
Email us here
April 21-23, 2020 – Genomic Landscapes: Leveraging Genetic Evidence throughout the Pharma Pipeline
Founder & CSO Mark Kiel, MD, PhD is a Featured Speaker at the LabRoots Genetics Virtual Week
Realizing the promise of Precision Medicine requires both a deep understanding of the landscape of genomic evidence and an understanding of the molecular drivers that influence all aspects of the drug development pipeline. Using real-world examples, Dr. Kiel demonstrates how Genomenon has overcome these obstacles and is being used by pharmaceutical companies to provide invaluable insight into the genomic drivers of disease.
Learn more and register to watch on-demand
April 16, 2020 – Mastermind Masterclass: Human Phenotype Ontology (HPO)
With the release of version 2.0, the Mastermind Genomic Search Engine now includes the ability to search the genomic literature by phenotype. Co-founders, CSO Dr. Mark Kiel and CTO Steve Schwartz led a virtual guided tour of the new HPO search feature and live Q&A.
View the recording and Q&A here
March 26, 2020 – Webinar: Using Genomics to Accelerate Drug Development for Neurodegenerative Diseases
In this webinar, Founder & CSO Dr. Mark Kiel will used real-world examples to demonstrate how a Comprehensive Genomic Landscape for a disease, pathway or gene set has empowered Pharmaceutical researchers and translational teams to understand genetic and rare diseases at the molecular level.
View the recording and Q&A here
March 1- 4, 2020 – Molecular Med TRI-CON & Bio IT West
Genomenon exhibited at Booth #302
The International Molecular Medicine Tri-Conference, entering its 27th year, is one of the most comprehensive and leading industry events in the personalized medicine space today. The Tri-Conference brings together more than 3,100 innovative thinkers and thought leaders in the field of drug discovery, development and diagnostics, informatics, and digital health throughout pharma, biotech, and academia. If you were unable to schedule a meeting with our leadership team in San Francisco, you can contact us by sending us an email below.
Email us here
February 25-27, 2020 – 8th Annual Neurodegenerative Drug Development Summit
Genomenon attended
The Genomenon leadership team was in Boston for the 8th Annual Neurodegenerative Drug Development Summit. This event brought together over 150 neurodegeneration experts to enable them to overcome their translational challenges and successfully translate into the clinic. If we were unable to connect with you in Boston at this event, you can contact us by sending us an email below.
Email us here
January 21-24, 2020 – Precision Medicine World Conference – Silicon Valley
Founder & CSO Mark Kiel, MD, PhD presented, ‘Curating the Entire Human Genome at Scale’
PMWC is a gathering of recognized leaders, top global researchers and medical professionals, plus innovators across healthcare and biotechnology sectors.
View Dr. Kiel’s presentation
January 13-15, 2020 – 2020 Digital Medicine & Medtech Showcase
Mike Klein, Genomenon’s CEO presented, “Leveraging A.I. and Genomics to Drive Rare Disease Drug Development” on Wednesday, January 15th, 2020 at 11:45 a.m. at the Parc 55 San Francisco hotel. If you were unable to attend this presentation, email us to learn more about Genomenon.
Email us here
January 12-16, 2020 – JP Morgan Healthcare Conference
Members of the Genomenon leadership team were in San Francisco during the JP Morgan Healthcare Conference, the most informative healthcare investment symposium in the industry. The conference brought together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
January 8, 2020 – BioArbor: Potential for AI and Machine Learning in Healthcare and Life Sciences
Genomenon founder & CTO Steve Schwartz was a featured panelist
Artificial intelligence. Machine learning. These buzzwords are the latest rage. But what do they really mean for the future of healthcare delivery and the life sciences industry? How are they being applied? Hear from a spectrum of viewpoints and backgrounds at the next BioArbor: Ann Arbor’s life science forum. BioArbor events are free and open to all bio-industry professionals and enthusiasts.
Learn more about BioArbor
November 12, 2019 – Cutting Edge/Drug Discovery & Development in Michigan
The Cutting Edge/Drug Discovery & Development in Michigan Symposium showcased drug R&D activities at the state’s research institutions and biotech/pharma companies and discuss their science, capabilities, and enterprises. Dr. Mark Kiel presented, “Curating the Genome to Drive Drug Discovery”.
View Dr. Kiel’s presentation
November 7-9, 2019 – Association for Molecular Pathology Annual Meeting & Expo (AMP)
The Genomenon team attended the 2019 AMP meeting – the premier gathering for molecular professionals. This year is the 25th anniversary and the technical advancements and legislative achievements were celebrated as the organization looks to the future and explores how to continue to provide the highest quality of care for patients in an evolving medical landscape.
Learn More
October 15-19, 2019 – American Society of Human Genetics Annual Meeting (ASHG)
At ASHG 2019 in Houston, Genomenon welcomed two leaders from UPMC and Rady Children’s Hospital who shared the tools and processes that are in place now, along with their plans for the future during a special CoLab session: How Rady Children’s Institute and University of Pittsburgh Medical Center are Automating Literature Curation and Variant Interpretation.
Learn More
October 10-11, 2019 – Precision Medicine Leaders Summit
Dr. Mark Kiel participated as a panelist during the Precision Medicine Leaders Summit moderated by Barbara Kraatz Fortini, PhD, Assistant Professor of Genetics and MSGDA Program Coordinator, School of Pharmacy and Health Science, Keck Graduate School. The event included the most thought-provoking Precision Medicine leaders in healthcare who are shaping the way Precision Medicine is implemented into healthcare systems on a global scale.
Learn More
September 11-12, 2019 – Clinical Biomarkers & World CDx
Dr. Mark Kiel presented on Optimizing Clinical Trial Design with Comprehensive Genomic Landscapes. Questions answered: What is the best way to understand the pathophysiology of a pathway or disease? How do you identify gene fusion partners to facilitate the development of targeted drugs?
Why is it important to understand the genomic landscape of a pathway or disease prior to selecting patient cohorts for clinical trials?
Learn More
June 15-18, 2019 – European Human Genetics Conference
Genomenon attended EHGS in Gothenburg, Sweden which provides workshops, instruction on human genetics and an environment to connect with others in the field of genetics from around the world. There were speakers from the various sectors of human genetics including educational talks, platform presentations and product exhibits for both clinical and laboratory work.
Learn More
June 3-6, 2019 – Bio International Convention
MIke Klein, CEO of Genomenon presented an overview on how Genomenon has partnered with pharmaceutical and bio-pharma customers to deliver a comprehensive genomic landscape around specific diseases for drug discovery and clinical trial target selection. The BIO International Convention is hosted by the Biotechnology Innovation Organization (BIO), which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.
Learn More
May 10, 2019 – Precision Genomics Midwest
PGM is the first Midwest regional conference focused exclusively on genomic research, translation and ethics.
The third annual Precision Genomics Midwest – the region’s largest genomics conference. PGM features talks by thought leaders in research, clinical, and translational genomics…and a top-quality vendor fair, showcasing the field’s leading-edge products and services.
Learn More
May 8-9, 2019 – Labroots Genetics and Genomics Virtual Event
Dr. Mark Kiel, CSO and Co-Founder of Genomenon presented on the topic of, “AI-Driven Literature Curation for Determining Genomic Variant Pathogenicity”. Dr. Kiel will discussed challenges to automating variant interpretation while improving the accuracy and reproducibility of the process using Mastermind – the world’s most comprehensive literature-based Genomic Search Engine.
Learn More
April 16-18, 2019 – Bio-IT World Conference & Expo
Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad of IT and informatics applications and enabling technologies that drive biomedical research, drug discovery & development, and clinical and healthcare initiatives. Genomenon attented this special industry event.
Learn More
April 2-4, 2019 – The Annual Clinical Genetics Meeting
Genomenon exhibited at this event
Come visit us at Booth #620 to try Mastermind Genomic Search Engine, complete with ACMG variant classification filters. This tool quickly identifies and prioritizes articles which cite evidence for ACMG classification criteria for each variant, such as those that include functional studies, segregation information, and more. We will be giving away 100 decks of Variant Interpretation Cards. Come and get yours! Follow this link to request a meeting.
Learn More
March 28, 2019 – Webinar: Characterizing Targeted Cancer Therapies via a Comprehensive Gene Fusion Database
Co-Founder Mark Kiel hosts the upcoming webinar
Genomenon has developed the most comprehensive database of gene fusion pairs found within the scientific literature. This complete literature catalogue for the 507 genes from the Illumina TruSight RNA Fusion Panel contains all known fusion pairs, with reference citations for every scholarly paper citing the chimeric genes. In this webinar, Genomenon’s CSO and co-founder Dr. Mark Kiel discusses how a Gene Fusion Database can be used to facilitate drug discovery and development.
View the Recording
March 21, 2019 – Startup Story Night in Detroit
Co-Founder Mark Kiel will share the Genomenon startup story
The New Economy Initiative (NEI), in partnership with Model D Media, is excited to announce the 3rd annual Startup Story Night. This year’s theme? “Don’t Call It A Comeback!”
We’re happy to announce four storytellers have been selected to workshop their stories with Shannon Cason – host, MainStage storyteller and GrandSlam champion with The Moth – before performing them in front of a live audience at The Marble Bar on Thursday, March 21, 2019.
Learn More
March 10-15, 2019 – Molecular Med Tri-Con
Leading technology to achieve patient care
The event held discussions about Molecular professionals leading the way in developing and applying new technologies to achieve the best patient care and outcome in this rapidly evolving field. Additionally, how they also play a vital role in educating our clinical colleagues, lay public, and elected officials of the value of the critical work that we do.
Learn More
January 20-23, 2019 – The Precision Medicine World Conference
Precision Medicine strategies changing how patients are treated
The Precision Medicine World Conference (PMWC), in its 16th installment, will take place in the Santa Clara Convention Center (Silicon Valley). Conference attendees had an opportunity to learn first-hand about the latest developments and advancements in precision medicine and cutting-edge new strategies and solutions that are changing how patients are treated.
Learn More
November 1-3, 2018 – AMP – Association for Molecular Pathology Meeting & Expo
Genomenon will be exhibiting at AMP, booth #902
The event held discussions about Molecular professionals leading the way in developing and applying new technologies to achieve the best patient care and outcome in this rapidly evolving field. Additionally, how they also play a vital role in educating our clinical colleagues, lay public, and elected officials of the value of the critical work that we do.
Learn More
October 16-20, 2018 – ASHG – American Society of Human Genetics – Annual Meeting
Genomenon presented a CoLab and exhibitied at ASHG, booth #1134
This year’s meeting attracted over 6,500 scientific attendees, plus almost 250 exhibiting companies. The meeting provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Dr. Mark Kiel held the workshop: “Reconciling inconsistency among commercial NGS gene panels with an evidence-based curation platform: Impact Study Results.”
Learn More
October 11-12, 2018 – Oxford Global R&D US Series
Genomenon exhibited at the Biomarkers & Precision Medicine Congress
The R&D US Series unites over 350 attendees from global pharmaceutical organisations, top biotech companies and internationally renowned academic institutions, alongside 30+ leading solution providers such as Fios Genomics, Histologix, Avacta, Randox Biosciences, Axio Research, Metabolon, ChemAxon and many more.
Learn More
September 19, 2018 – Webinar: Is Genomic Medicine Ready for A.I.?
Dr. Mark Kiel presents his thoughts on current uses of artificial intelligence (AI) for genome interpretation, challenges to successful application in clinical medicine, and more.
Genome sequencing promises to improve diagnostic accuracy and patient outcomes in both oncology
and genetics, but the volume and complexity of the data requires a significant manual process to ensure high-quality interpretation. In the wake of IBM Watson, is Genomic Medicine Ready for AI?
Watch the Recording
August 8, 2018 – Researchpalooza
Researchpalooza is a free networking event hosted by the University of Michigan Medical School of Research.
Over 91 different offices and labs who serve biomedical research across the University of Michigan campus and beyond gather for this free ice cream social and networking event.
Learn More
July 11, 2018 – Webinar with Veritas Genetics
Accelerating Patient Diagnosis with Automated Literature Curation for Inherited Disease
This webinar with special guests from Veritas Genetics discussed an approach for automating variant classification using the American College of Medical Genetics and Genomics guidelines.
Watch the Recording
June 6-7, 2018 – Precision Medicine World Conference, Ann Arbor
The theme for this year’s PMWC is “Big Data in Action: Data-Driven Insights in the Clinic”
The program will feature innovative technologies, and analyze the success of already thriving initiatives and clinical case studies that enable the translation of precision medicine into direct improvements in health care. Dr. Mark Kiel presented the talk “Is Genomic Medicine Ready for AI?”
June 15, 2018 – Tech Trek, Ann Arbor
Ann Arbor Tech Trek is a free community event and a terrific opportunity to see the real gems located in the Ann Arbor area
Leading technology companies will open their doors to the public and showcase their latest innovations. Whether you’re a job seeker, student, professional, or someone curious about the Ann Arbor tech community, anyone is welcome to attend. Genomenon demonstrated the Mastermind Genomic Search Engine at the event.
May 11, 2018 – Precision Genomics Midwest, Cincinnati
PGM is the first Midwest regional conference focused exclusively on genomic research, translation and ethics.
Genomenon exhibited and Dr. Mark Kiel will be speaking at the Precision Genomics Conference at Cincinnati Children’s in May.
April 10-14, 2018 – ACMG – Annual Clinical Genetics Meeting
American College of Medical Genetics and Genomics Meeting – Charlotte, N.C.
Presentation: Faster Patient Diagnosis: Automated ACMG Variant Classification
Speakers: Birgit Funke, PhD, Veritas Genetics; Mark Kiel, MD, PhD, Genomenon
April 3, 2018 – Webinar: Automated Biomarker Selection for Evidence-Based Gene Panel Design
Automated Biomarker Selection for Evidence-Based Gene Panel Design
Dr. Mark Kiel presented the biomarker selection process and results for the first comprehensive evidence-based Pan-Hematopoietic Malignancy Gene Panel using the Mastermind Genomic Search Engine.
Watch the Recording
Feb 15, 2018 – GenomeWeb Webinar
Mining Genomic Literature for Variant Interpretation and Gene Panel Design
University of Vermont Health System’s Dr. Nikoletta Sidiropoulos and Dr. David Seward discussed variant interpretation using Mastermind. Q2 Solution’s Dr. Vic Weigman presented an evidence-based design approach for gene panels using Mastermind.
Watch the Recording
MASTERMIND GENOMIC SEARCH ENGINE
The Largest Source of Genomic Literature
The Largest Source of Genomic Literature